$CMTG

Mack Richard purchased $351K of CMTG

Mack Richard (CEO AND CHAIRMAN) purchased 220,603 shares of Claros Mortgage Trust, Inc. (CMTG) at an average of $1.59 ($1.59–$1.59, $0.35M total) across 2 trades over 2026-09-03 to 2026-09-04.

Original reporting
SEC EDGAR · Mack Richard
Published Sep 8, 2026, 8:44 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 8, 2026, 9:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CMTG
Neutral
high confidence
Mentioned
$CMTG
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CMTGNeutralLow
01

Why it matters

The purchase modestly raises confidence in management but unlikely to affect market price.

02

Market read

Routine insider purchase with limited trading relevance.

03

What to watch

Potential upcoming corporate actions not disclosed.

Relevance 5/10Novelty 4/10Timing: filed Sep 8, 2026

Background

Form 4 filing reports insider transactions; used by traders to gauge insider sentiment.

Company-level read

Ticker impact

$CMTGNeutralHigh confidence
Context

CEO Mack Richard bought 220,603 shares for $351,241, increasing his stake to over 3.1 million shares.

Expected impact

minimal impact, possible slight positive bias

Evidence & confidence

Purchase size under $1M and typical for insider accumulation; market likely views as routine.

Market effects

None significant for mortgage REIT sector.

No regional effect.

Limited to CMTG shareholders.

Counterpoint

Insider buying could signal confidence despite modest size.

Key entities

  • Claros Mortgage Trust, Inc.

    Mortgage REIT listed on NYSE under ticker CMTG.

  • Mack Richard

    CEO and Chairman of Claros Mortgage Trust.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CMTGMed

Claros Mortgage Trust, Inc. (CMTG): Reports Second Quarter 2026 Results

Claros Mortgage Trust, Inc. (CMTG) filed an SEC Form 8-K — Results of Operations and Financial Condition. Claros Mortgage Trust, Inc. Reports Second Quarter 2026 Results New York, NY, July 29, 2026 – Claros Mortgage Trust, Inc. (NYSE: CMTG) (the “Company” or “CMTG”) today reported its financial results for the quarter ended June 30, 2026. The Company reported GAAP net loss of $255.4

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).